Home › Funds › Dundas Partners LLP › RMD
Dundas Partners LLP position in RMD
RESMED INC · Health Care
Dundas Partners LLP reported holding 203,021 shares of RMD (RESMED INC) in its Q3 2026 13F filing — a position valued at US$44.9M, representing 3.56% of its reported portfolio and ranking #11 among its reported holdings. Dundas Partners LLP has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Dundas Partners LLP's RMD position evolved
Dundas Partners LLP first disclosed a stake in RMD in Q1 2024 at 108,868 shares (US$21.6M). The position peaked in Q4 2025 at 204,962 shares, worth US$49.4M. Across 11 filings, Dundas Partners LLP increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 203,021 shares valued at US$44.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 108.87K | $21.56M | New |
| Q2 2024 | 132.69K | $25.40M | Add |
| Q3 2024 | 140.56K | $34.31M | Add |
| Q4 2024 | 140.56K | $32.15M | Hold |
| Q1 2025 | 152.18K | $34.07M | Add |
| Q2 2025 | 152.18K | $39.26M | Hold |
| Q3 2025 | 175.12K | $47.93M | Add |
| Q4 2025 | 204.96K | $49.37M | Add |
| Q1 2026 | 203.02K | $45.57M | Reduce |
| Q2 2026 | 203.02K | $39.56M | Hold |
| Q3 2026 | 203.02K | $44.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RMD and 13F data
RMD (RESMED INC) is a Health Care company. 31 other funds we track also report a position in RMD — the largest reported positions include Ilex Capital Partners (UK) LLP (US$163.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RMD
- Ilex Capital Partners (UK) LLP 737.47K sh · $163.06M · Q3 2026
More on Dundas Partners LLP
FAQ
How long has Dundas Partners LLP held RMD?
Dundas Partners LLP has disclosed RMD holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Dundas Partners LLP's current position in RMD?
As of Q3 2026, Dundas Partners LLP holds 203.02K shares of RMD (RESMED INC), valued at $44.89M, representing 3.56% of its reported portfolio and ranking #11.
Has Dundas Partners LLP been buying or selling RMD?
In the latest 13F filing (Q3 2026), Dundas Partners LLP held unchanged its position in RMD. The position peaked in Q4 2025 at 204.96K shares.
Which other funds hold RMD?
Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.